Information for "TARGET"
Jump to navigation
Jump to search
Basic information
| Display title | TARGET |
| Redirects to | Comparison Of Two Platelet Glycoprotein IIb/IIia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization (info) |
| Default sort key | TARGET |
| Page length (in bytes) | 182 |
| Namespace ID | 0 |
| Page ID | 173350 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | DaveBot (talk | contribs) |
| Date of page creation | 19:20, 6 July 2009 |
| Latest editor | DaveBot (talk | contribs) |
| Date of latest edit | 19:20, 6 July 2009 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |